Dynamic Immune Responsiveness in Breast Cancer: Tumor Microenvironment Plasticity, Therapeutic Timing, and Clinical Translation
Breast cancer immunotherapy has advanced substantially, yet durable clinical benefit remains limited to selected patient populations, reflecting heterogeneity in tumor–immune interactions across molecular subtypes, disease stages, and treatment contexts. This review frames immune responsiveness as a dynamic manifestati...